Table 2.
Associations between complication grade and pathology
| Highest Clavien–Dindo grade | ||||||
|---|---|---|---|---|---|---|
| Total n † | Overall | None | I–II | III–V | P ‡ | |
| Type of tumour | 430 | n = 138 | n = 144 | n = 148 | 0·490§ | |
| Adenocarcinoma | 337 (78·4) | 110 (79·7) | 119 (82·6) | 108 (73·0) | ||
| Squamous | 70 (16·3) | 21 (15·2) | 17 (11·8) | 32 (21·6) | ||
| Adenosquamous | 8 (1·9) | 2 (1·4) | 4 (2·8) | 2 (1·4) | ||
| Other | 15 (3·5) | 5 (3·6) | 4 (2·8) | 6 (4·1) | ||
| Tumour location | 392 | n = 118 | n = 134 | n = 140 | 0·208§ | |
| GOJ | 236 (60·2) | 81 (68·6) | 74 (55·2) | 81 (57·9) | ||
| Distal | 132 (33·7) | 30 (25·4) | 51 (38·1) | 51 (36·4) | ||
| Middle | 24 (6·1) | 7 (5·9) | 9 (6·7) | 8 (5·7) | ||
| pT category | 427 | n = 135 | n = 144 | n = 148 | 0·071 | |
| pT0 | 19 (4·4) | 5 (3·7) | 8 (5·6) | 6 (4·1) | ||
| pT1 | 52 (12·2) | 13 (9·6) | 18 (12·5) | 21 (14·2) | ||
| pT2 | 54 (12·6) | 15 (11·1) | 14 (9·7) | 25 (16·9) | ||
| pT3 | 277 (64·9) | 93 (68·9) | 96 (66·7) | 88 (59·5) | ||
| pT4 | 25 (5·9) | 9 (6·7) | 8 (5·6) | 8 (5·4) | ||
| pN category | 429 | n = 137 | n = 144 | n = 148 | 0·882 | |
| pN0 | 164 (38·2) | 57 (41·6) | 46 (31·9) | 61 (41·2) | ||
| pN1 | 186 (43·4) | 57 (41·6) | 65 (45·1) | 64 (43·2) | ||
| pN2 | 46 (10·7) | 13 (9·5) | 20 (13·9) | 13 (8·8) | ||
| pN3 | 33 (7·7) | 10 (7·3) | 13 (9·0) | 10 (6·8) | ||
| pM1 status | 430 | 9 (2·1) | 3 of 138 (2·2) | 2 of 144 (1·4) | 4 of 148 (2·7) | 0·757 |
| Overall stage | 425 | n = 134 | n = 144 | n = 147 | 0·428 | |
| 0 | 15 (3·5) | 4 (3·0) | 5 (3·5) | 6 (4·1) | ||
| 1 | 74 (17·4) | 18 (13·4) | 24 (16·7) | 32 (21·8) | ||
| 2 | 95 (22·4) | 39 (29·1) | 25 (17·4) | 31 (21·1) | ||
| 3 | 232 (54·6) | 70 (52·2) | 88 (61·1) | 74 (50·3) | ||
| 4 | 9 (2·1) | 3 (2·2) | 2 (1·4) | 4 (2·7) | ||
| Perineural invasion | 331 | 105 (31·7) | 38 of 114 (33·3) | 40 of 115 (34·8) | 27 of 102 (26·5) | 0·291 |
| Tumour dimensions (mm) * | ||||||
| Length | 394 | 35 (25–45) | 35 (25–45) | 34 (25–45) | 35 (25–48) | 0·766¶ |
| Width | 382 | 26 (20–40) | 25 (18–40) | 25 (20–35) | 30 (20–37) | 0·774¶ |
| Depth | 310 | 12 (8–15) | 12 (8–16) | 11 (7–15) | 12 (8–16) | 0·634¶ |
| Maximum dimension | 402 | 35 (25–50) | 36 (25–50) | 35 (25–50) | 35 (25–50) | 0·753¶ |
Values in parentheses are percentages unless indicated otherwise;
*
values are median (i.q.r.).
†
Number of patients with data available for the stated factor. GOJ, gastro‐oesophageal junction.
‡
Kendall's τ, except
§
Kruskal–Wallis test and
¶
Jonckheere–Terpstra test.